Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF
Clinical Efficacy of Personalized Exercise Program and an Inhibitor of Fatty Acid β-oxidation in Rehabilitation of Patients With Atrial Fibrillation After Primary Radiofrequency Ablation of Pulmonary Venous Orifices
Sponsor: National Research Center for Preventive Medicine
This NA trial investigates Atrial Fibrillation Paroxysmal and is currently completed. National Research Center for Preventive Medicine leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Sep 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2021 — Sep 2021 [monthly]
Completed NA
-
Jan 2021 — Jun 2021 [monthly]
Completed NA
-
Oct 2020 — Jan 2021 [monthly]
Completed NA
-
Sep 2020 — Oct 2020 [monthly]
Completed NA
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Research Center for Preventive Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.